The object of our study was to trace the derivation of the adult human cartilage stem cells, the fate decision of their stem cell characteristics, and their effectiveness for cartilage repair. Cells from human adult articular cartilage were isolated and analyzed. Adult articular cartilage samples (47-71 years old, Samples were randomly selected for all analyses, the specific number of biological replicates (=donors) used for each experiment is indicated in the figure legends.
included FITC-conjugated antibodies specific to human CD34 (clone 581, IgG1, κ), CD90 (clone 5E10, IgG1, κ), CD45 (clone 30-F11, IgG2a, κ, eBioscience) and PE-conjugated mouse antibody specific to human CD44 (clone 515, IgG1, κ). Non-conjugated mouse antibodies to human CD105 and CD146 (clone P1H12, Millipore) were used with FITC-conjugated rabbit anti-mouse IgG (Life Technologies). For double staining, another non-conjugated rabbit antibody specific to human CD146 (clone EPR3208, abcam) was used with a mouse anti-human collagen type II antibody (Calbiochem), and a goat anti-rabbit secondary antibody (Alexa Fluor 546, Life Technologies) was used to detect rabbit derived primary antibodies. For immunostaining, non-conjugated rabbit antibodies to human collagen type II (Millipore), human collagen type I (abcam), and human collagen type X (abcam). Immunoblotting was carried out using a phospho-SMAD antibody sampler Kit (#9936, Cell signaling) to analyze SMAD signaling, and protein load was assessed with a control mouse anti-human GAPDH monoclonal antibody (mAbcam9484, Abcam).
Multilineage differentiation and quantification
Osteogenesis, adipogenesis, and chondrogenesis of CDPCs and BMSCs were tested. Osteogenic induction: CDPCs and BMSCs were plated at low density (1,000 cells/cm 2 ) on tissue-culture-treated 24 well plates and cultured for 2 weeks in DMEM-high glucose containing 10 % FBS, 10 mM β-glycerophosphate (Sigma-Aldrich), 0.1 μM dexamethasone (Sigma-Aldrich), and 50 μg/ml ascorbic acid (Sigma-Aldrich). The medium was changed every 3 days. Alizarin red (Sigma-Aldrich) staining was quantified spectrophotometrically on the basis of A 405 and normalized to cell number estimated from DAPI staining and calculation by Image J (NCBI). Adipogenic induction: CDPCs and BMSCs were grown to confluence followed by treatment for 2 weeks with 1 mM dexamethasone, 10 μg/ml insulin, and 0.5 mM isobutylxanthine (all from Sigma-Aldrich) in DMEM-high glucose containing 10 % FBS. Medium was changed every 3 days. Oil Red-O staining was collected by isopropanol and quantified spectrophotometrically based on A 510 and normalized to cell number. Chondrogenic induction: CDPCs and BMSCs in high density pellet cultures were treated with 10 ng/ml transforming growth factor-3 (TGF-β3, PeproTech), 50 μg/ml ascorbic acid, 40 μg/ml proline, and 0.1 μM dexamethasone in DMEMhigh glucose medium containing Insulin/Transferrin/Selenium (ITS) ethanolamine Solution (ITS-X, Life Technologies). High density pellets were created by pre-incubating the cells in FBS-free medium 4-6 h, and aliquots of 2×10 5 cells in 0.5 ml medium were pelleted by centrifugation (300 g, 5 min) in a 15 ml polypropylene conical tube. Within 24-48 hr after incubation, cells aggregated to form a pellet. The medium was changed every 2-3 days, and cell aggregates were obtained at intervals of as long as 21
days. sGAG content in the pellet was assessed by Safranin-O staining, and histological analysis was performed according to a previously published pellet scoring system (Grogan et al., 2006) . To generate hyaline 3D cartilage-like tissue in vitro, 2 × 10 6 CDPCs were seeded within the insert in a Transwell culture plate (Corning) and treated with chondrogenic medium containing TGF-3 (10 ng/ml) and/or bone morphogenetic protein-4 (BMP4, 10 ng/ml; PeproTech). Samples were collected at week 9 for histological, gene expression, and immunoblot analyses.
Acellular cartilage-derived matrix
Acellular cartilage matrix (AM) was prepared using a combination of physical, chemical and enzymatic treatments (Yin et al., 2013) . In brief, fresh bovine articular cartilage and meniscus cartilage samples were minced into ~10 mm 3 fragments, frozen at -80°C overnight, and pulverized in liquid nitrogen using a freezer mill (6870, SPEX SamplePrep). The tissue powder was decellularized by incubation in 1% Triton X-100 (Sigma-Aldrich) in PBS under continuous agitation for 24 h at 4 °C, followed by three washes, 30 min each in PBS, and treatment with 200 U/ml DNase and 50 U/ml RNase (Worthington) at 37 °C for
Pilot Clinical Study

Patient enrollment and study design
A prospective pilot clinical study was designed to evaluate the feasibility of the therapeutic application of CDPCs. Inclusion criteria for a total of 15 patients were large full-thickness cartilage lesions [more than 6 cm 2 in size, International Cartilage Repair Society (ICRS) grade III to IV] on the femoral condyle of the knee and age up to 40 years. Exclusion criteria were inflammatory lesion and joint instability, and other chronic knee pathologies; previous major surgeries of the knee, or other conditions known to compromise cartilage repair. The patients gave consent for MACT as a two-stage process, with a followup arthroscopy procedure including biopsy approximately 1 year after the second stage of the procedure. Additionally, patients were informed that data derived from their procedures would be submitted for publication, and they gave their consents. This study was approved by the Ethics Review
Committee of School of Medicine, Zhejiang University, China.
A total of 15 patients (2 females and 13 males) with a mean age of 25.0 years (range: 16-36) were included in the prospective pilot study. All patients gave informed consent, and treatment was approved by the local ethics board. The sites of the defects were the following: medial femoral condyle (n=9) and lateral femoral condyle (n=5), medial femoral condyle extending to trochlea glove (n=1). The average size of the defects was 8.5 cm 2 (range: 6-13 cm 2 ) and the defects were classified as Grade III and IV according to ICRS criteria.
Surgical implantation procedure
A diagnostic arthroscopy is performed to evaluate the defect and to assess the joint for any potential comorbidities, such as ligamentous instability, meniscal deficiency, etc. The number, size, and location of chondral defects are noted. The quality and thickness of the surrounding articular cartilage was assessed to determine whether the lesion was contained or uncontained, and whether a rim of healthy cartilage was available for MACT suturing. If the defects were found to be amenable to MACT, a fullthickness cartilage specimen was harvested with a sharp gouge from a non-weight bearing area of the trochlear ridge or intercondylar notch.
After removal from the joint, the cartilage was then placed into a transport medium, and transported to the cell laboratory for preparation of the CDPC-based MACT implant. Cells were isolated via an enzymatic processes, and expanded at low density in monolayer culture under low glucose conditions.
The culture medium was supplemented with serum taken from the patient's blood at the time of surgery under good manufacturing practice (GMP) conditions. After 2-3 weeks culture in vitro, the CDPC-seeded implant (~1 x 10 6 cells/cm 2 ) (Foldager et al., 2012) was then transported back to the surgeon and surgically implanted into the cartilage defects.
Implantation
The operative technique used was similar to other surgical techniques for the treatment of cartilage defects before membrane implantation (Brittberg et al., 1994) . Surgical exposure of the lesion for the MACT technique involved a mini-arthrotomy, the extent of which depended on the size and location of the cartilage lesions. The defect site was debrided back to a rim of stable, normal cartilage using a nonangulated, round-eyed sharp curette. All fissured and undermined cartilage was removed using small curettes. The debridement was performed on the subchondral bone plate, avoiding any perforations or subchondral bleeding. After debridement, the lesion size was measured and a template made and used to size the MACT implant accordingly. The MACT implant was then fixed into the defect with fibrin glue and peripheral stitches. Pressure was applied for several minutes to ensure fixation of the MACT implant, and the stability of the transplant was tested by intraoperative movement of the joint. In particular, for two patients who presented with significant subchondral bone defects (9 cm 2 and 10 cm 2 cartilage defects, respectively), autologous bone graft was also performed in the MACT procedure.
Rehabilitation
Continuous passive motion (CPM) was started on the first postoperative day, with daily increases in range of motion (Edwards et al., 2014) . CPM was used 6-8 h daily for up to 6 weeks postoperatively.
Isometric strengthening of the quadriceps began in the first week, while partial weight bearing was allowed after 6 weeks and full weight bearing after 10 weeks.
Imaging assessment
MR imaging was performed with a 3.0-Tesla magnet using a knee coil preoperatively and at 1 year postoperatively. Imaging was performed in the sagittal plane, and a series of T1-weighted and T2-weighted images were obtained as routine sequences. Fat-suppressed three-dimensional fast spoiled gradient-recalled (3D-FSPGR) sequences were also performed to obtain additional morphological details, with 1.5-mm slice thickness (Domayer et al., 2010; Kornaat et al., 2005) . Evaluation of MR images was performed by two skilled musculoskeletal radiologists.
Clinical evaluation
All 15 patients were evaluated based on IKDC and Lysholm scoring before and after surgery. Postsurgical evaluation was carried out a year after surgery.
Post-operative tissue biopsies and histology
A juvenile bone marrow biopsy needle was used during arthroscopy to obtain a core biopsy of the repair tissue as close as possible to the center of the treated defect, with the aim of acquiring the cartilage repair tissue. A total of 4 repair tissue core biopsies of <3 mm diameter, were taken at 12 months postoperation. The specimens were fixed and decalcified (12% EDTA, pH 7.0), dehydrated in graded ethanol solutions and xylene, and sectioned. Following paraffin embedment, 6 µm thick sections are cut and stained with either haematoxylin and eosin (H&E) for histological assessment of the general morphology of the repair tissue, or Safranin O for sGAG staining.
Statistical analysis
A paired Student's t test was used for statistical evaluation, with significant difference defined as p < 0.05. 
